146 related articles for article (PubMed ID: 9139339)
21. Local cardiac renin-angiotensin system: hypertension and cardiac failure.
Varagic J; Frohlich ED
J Mol Cell Cardiol; 2002 Nov; 34(11):1435-42. PubMed ID: 12431442
[TBL] [Abstract][Full Text] [Related]
22. [Angina pectoris and a normal coronary angiogram in arterial hypertension and left ventricular hypertrophy].
Motz W; Kelm M; Schwartzkopff B; Strauer BE
Dtsch Med Wochenschr; 1994 Aug; 119(34-35):1175-80. PubMed ID: 8076507
[No Abstract] [Full Text] [Related]
23. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
Duprez DA
J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin receptors in the cardiovascular system.
Wagenaar LJ; Voors AA; Buikema H; van Gilst WH
Can J Cardiol; 2002 Dec; 18(12):1331-9. PubMed ID: 12518185
[TBL] [Abstract][Full Text] [Related]
25. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
[TBL] [Abstract][Full Text] [Related]
26. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
Carnovali M
Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
[TBL] [Abstract][Full Text] [Related]
27. [New aspects of the pathophysiology and pathogenesis of arterial hypertension--a review of the literature].
Franz C; Linss G; Franz N
Z Gesamte Inn Med; 1990 Dec; 45(24):723-8. PubMed ID: 2151671
[TBL] [Abstract][Full Text] [Related]
28. The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications.
Cooper ME
Am J Hypertens; 2004 Nov; 17(11 Pt 2):16S-20S; quiz A2-4. PubMed ID: 15539106
[TBL] [Abstract][Full Text] [Related]
29. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
[TBL] [Abstract][Full Text] [Related]
30. Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria.
Williams JS; Williams GH; Jeunemaitre X; Hopkins PN; Conlin PR
J Hum Hypertens; 2005 Feb; 19(2):133-8. PubMed ID: 15361890
[TBL] [Abstract][Full Text] [Related]
31. [Arterial hypertension and cardiac arrhythmias].
Vester EG
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S261-5. PubMed ID: 19085803
[TBL] [Abstract][Full Text] [Related]
32. The what, why and how of hypertensive heart disease.
Weber KT
J Hum Hypertens; 1994 Sep; 8(9):665-75. PubMed ID: 7807496
[TBL] [Abstract][Full Text] [Related]
33. AGT and AT1R gene polymorphism in hypertensive heart disease.
Mettimano M; Romano-Spica V; Ianni A; Specchia M; Migneco A; Savi L
Int J Clin Pract; 2002 Oct; 56(8):574-7. PubMed ID: 12425365
[TBL] [Abstract][Full Text] [Related]
34. [Hypertension and the progression of organ damage].
Morganti A
Ital Heart J; 2000 Jun; 1 Suppl 2():100-3. PubMed ID: 10905136
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II receptor blockers in the treatment of the cardiovascular disease continuum.
Chrysant SG
Clin Ther; 2008; 30 Pt 2():2181-90. PubMed ID: 19281913
[TBL] [Abstract][Full Text] [Related]
36. Hypertension and cardiac arrhythmias: a review of the epidemiology, pathophysiology and clinical implications.
Yiu KH; Tse HF
J Hum Hypertens; 2008 Jun; 22(6):380-8. PubMed ID: 18337759
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase-dependent EGF receptor activation in hypertension and left ventricular hypertrophy.
Shah BH; Catt KJ
Trends Endocrinol Metab; 2004 Aug; 15(6):241-3. PubMed ID: 15358274
[TBL] [Abstract][Full Text] [Related]
38. Heart failure: how important is cellular sequestration? The role of the renin-angiotensin-aldosterone system.
De Mello WC
J Mol Cell Cardiol; 2004 Aug; 37(2):431-8. PubMed ID: 15276013
[TBL] [Abstract][Full Text] [Related]
39. [The connection between late ventricular potentials and ventricular arrhythmias in hypertension patients with different forms of myocardial hypertrophy].
Gusarov GV; Moroshkin VS
Ter Arkh; 1998; 70(8):48-52. PubMed ID: 9770745
[TBL] [Abstract][Full Text] [Related]
40. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
